GENX OTC
Genex Pharmaceutical, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -99.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$530K
-55.1% ▼
Capital Expenditures
$1K
+64.6% ▲
4Y CAGR: -19.8%
Free Cash Flow
$528K
-55.1% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$238K
+328.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2003 | FY2004 | FY2005 | FY2006 | FY2007 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$52K | $1M | $625K | $619K | $343K |
| Depreciation & Amort. | $3K | $59K | $60K | $55K | $56K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $4K | -$982K | $667K | $500K | -$472K |
| Other Non-Cash Items | $3K | $0 | $25K | $6K | $603K |
| Operating Cash Flow | -$42K | $90K | $1M | $1M | $530K |
| — Investing Activities — | |||||
| Capital Expenditures | -$3K | -$6K | -$1K | -$4K | -$1K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | -$1M | -$2M |
| Investing Cash Flow | -$3K | -$6K | -$1K | -$1M | -$2M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | -$1M | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $37K | $6K | $2M |
| Financing Cash Flow | $42K | $0 | -$1M | $6K | $2M |
| Net Change in Cash | -$3K | $84K | -$30K | -$104K | $238K |
| Cash End of Period | $10K | $326K | $296K | $192K | $430K |
| Free Cash Flow | -$45K | $84K | $1M | $1M | $528K |